Evidence map›Paper›PMID 29215200›Full record

ArticleJournal of cachexia, sarcopenia and muscle2018

miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting.

Martin Connolly, Richard Paul, Roser Farre-Garros, Samantha A Natanek, Susannah Bloch, Jen Lee, Jose P Lorenzo, Harnish Patel, Cyrus Cooper, Avan A Sayer and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05456997 (Prospective Observational Study of Metabolic Myopathy in Cushing's Syndrome or Pheochromocytoma Patients Undergoing Adrenalectomy), which is not on this map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05456997 terminatednot on this mapstarted 2023, after this paper: background citation

Prospective Observational Study of Metabolic Myopathy in Cushing's Syndrome or Pheochromocytoma Patients Undergoing Adrenalectomy

TypeobservationalSponsorBarts & The London NHS TrustRan2023 to 2023Enrolled1ConditionsCushing Syndrome, Pheochromocytoma, Conns Syndrome, Metabolic MyopathyArmsMuscle biopsy
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Epigenetics of Skeletal Muscle Atrophy.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Article
  14. miR-424(322)-5p targetsActa biochimica et biophysica Sinica · 2023
    Article
  15. Ribosome biogenesis in disease: new players and therapeutic targets.Signal transduction and targeted therapy · 2023
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Sequence Requirements for miR-424-5p Regulating and Function in Cancers.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Martin ConnollyMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Richard PaulMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Roser Farre-GarrosMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Samantha A NatanekMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Susannah BlochMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Jen LeeMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Jose P LorenzoMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Harnish PatelMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, UK.
Cyrus CooperMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, UK.
Avan A SayerMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, UK.
Stephen J WortNational Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, SW3 6NP, UK.
Mark GriffithsInflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Michael I PolkeyNational Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, SW3 6NP, UK.
Paul R KempMolecular Medicine Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Imperial College London · GBNational Institute for Health Research · GBMRC Lifecourse Epidemiology Unit · GBNIHR Newcastle Biomedical Research Centre · GBSouthampton General Hospital · GB

Funding

British Heart Foundation FS/14/71/31038Medical Research Council G0400491Medical Research Council G0901955Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UP_A620_1015Medical Research Council MC_UP_A620_1017Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12011/2Medical Research Council MC_UU_12011/4
6 · The paper itself

Abstract

backgroundA loss of muscle mass occurs as a consequence of a range of chronic and acute diseases as well as in older age. This wasting results from an imbalance of protein synthesis and degradation with a reduction in synthesis and resistance to anabolic stimulation often reported features. Ribosomes are required for protein synthesis, so changes in the control of ribosome synthesis are potential contributors to muscle wasting. MicroRNAs (miRNAs) are known regulators of muscle phenotype and have been shown to modulate components of the protein synthetic pathway. One miRNA that is predicted to target a number of components of protein synthetic pathway is miR-424-5p, which is elevated in the quadriceps of patients with chronic obstructive pulmonary disease (COPD).

methodsTargets of miR-424-5p were identified by Argonaute2 pull down, and the effects of the miRNA on RNA and protein expression were determined by quantitative polymerase chain reaction and western blotting in muscle cells in vitro. Protein synthesis was determined by puromycin incorporation in vitro. The miRNA was over-expressed in the tibialis anterior muscle of mice by electroporation and the effects quantified. Finally, quadriceps expression of the miRNA was determined by quantitative polymerase chain reaction in patients with COPD and intensive care unit (ICU)-acquired weakness and in patients undergoing aortic surgery as well as in individuals from the Hertfordshire Sarcopenia Study.

resultsPull-down assays showed that miR-424-5p bound to messenger RNAs encoding proteins associated with muscle protein synthesis. The most highly enriched messenger RNAs encoded proteins required for the Pol I RNA pre-initiation complex required for ribosomal RNA (rRNA) transcription, (PolR1A and upstream binding transcription factor). In vitro, miR-424-5p reduced the expression of these RNAs, reduced rRNA levels, and inhibited protein synthesis. In mice, over-expression of miR-322 (rodent miR-424 orthologue) caused fibre atrophy and reduced upstream binding transcription factor expression and rRNA levels. In humans, elevated miR-424-5p associated with markers of disease severity in COPD (FEV

conclusionsThese data suggest that miR-424-5p regulates rRNA synthesis by inhibiting Pol I pre-initiation complex formation. Increased miR-424-5p expression in patients with conditions associated with muscle wasting is likely to contribute to the inhibition of protein synthesis and loss of muscle mass.

Indexed as

AnimalsCell LineHumansMaleMiceMice, Inbred C57BLMicroRNAsMuscular AtrophyProtein BiosynthesisRNA, RibosomalTransfectionMicroRNAsMIRN424 microrna, humanMIRN424 microRNA, mouseRNA, RibosomalmicroRNAMuscle wastingProtein synthesisRibosomal RNA synthesis

Identifiers

PMID29215200
PMCPMC5879973
OpenAlexW2773551205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.